Exclusive: CVC and Temasek to buy generics firm Alvogen, Alvogen's CEO says

lundi 22 juin 2015

Woman passes a logo of state investor Temasek Holdings at their office in SingaporeEuropean private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said. Robert Wessman, former CEO of Actavis, founded the New Jersey-based generic drugs firm in 2009. Wessman sold a stake in the business to the private equity fund Pamplona in 2014.




Exclusive: CVC and Temasek to buy generics firm Alvogen, Alvogen's CEO says source: http://finance.yahoo.com/news/exclusive-cvc-temasek-buy-generics-065657735.html

0 commentaires:

Enregistrer un commentaire